CENBF (CEN Biotech) Total Liabilities: $10.12 Mil (As of Mar. 2023)


What is CEN Biotech Total Liabilities?

CEN Biotech CENBF Total Liabilities is $10.12 Mil as of Mar. 2023.

CEN Biotech's Total Liabilities for the quarter that ended in Mar. 2023 was $10.12 Mil.

CEN Biotech's quarterly Total Liabilities increased from Sep. 2022 ($10.02 Mil) to Dec. 2022 ($10.15 Mil) but then declined from Dec. 2022 ($10.15 Mil) to Mar. 2023 ($10.12 Mil).

CEN Biotech's annual Total Liabilities declined from Dec. 2020 ($16.31 Mil) to Dec. 2021 ($10.10 Mil) but then increased from Dec. 2021 ($10.10 Mil) to Dec. 2022 ($10.15 Mil).

CEN Biotech Total Liabilities Historical Data

* Premium members only.

The historical data trend for CEN Biotech's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CEN Biotech Total Liabilities Chart

CEN Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Total Liabilities
Get a 7-Day Free Trial Premium Member Only 28.58 32.83 16.31 10.10 10.15

CEN Biotech Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.24 9.93 10.02 10.15 10.12

CEN Biotech Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

CEN Biotech's Total Liabilities for the fiscal year that ended in Dec. 2022 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=9.974+(0.177+-3.885780586188E-16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=10.15

Total Liabilities=Total Assets (A: Dec. 2022 )-Total Equity (A: Dec. 2022 )
=7.859--2.291
=10.15

CEN Biotech's Total Liabilities for the quarter that ended in Mar. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=9.987+(0.131+2.2204460492503E-16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=10.12

Total Liabilities=Total Assets (Q: Mar. 2023 )-Total Equity (Q: Mar. 2023 )
=7.447--2.672
=10.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $10.12 Mil mean?
CEN Biotech (CENBF) has a Total Liabilities of $10.12 Mil as of Mar. 2023. The total amount of liabilities as recorded on a company's balance sheet. View historical data for CEN Biotech and its competitors.
Is CEN Biotech's Total Liabilities too high?
CEN Biotech's current Total Liabilities is $10.12 Mil.
How does CEN Biotech's Total Liabilities compare to INLB and NEPT?
CEN Biotech's Total Liabilities of $10.12 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for CEN Biotech and its competitors. CEN Biotech's current Total Liabilities is $10.12 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CEN Biotech stock overvalued right now?
CEN Biotech (CENBF) has a current Total Liabilities of $10.12 Mil. The current Total Liabilities is $10.12 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For CEN Biotech (CENBF), the current Total Liabilities is $10.12 Mil as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CEN Biotech Business Description

Address 3295 Quality Way, Suite 300, Windsor, ON, CAN, N8T 3R9
CEN Biotech Inc is an early-stage Canadian biopharmaceutical company. The Company grows, sells, and delivers pharmaceutical-grade medical marijuana to patients.